Opportunistic Infection and Nuclear Medicine

Seminars in Nuclear Medicine

Volumn 39, Issue 2, 2009, Pages 88-102

  O'Doherty, Michael J ^a,b   Barrington, Sally F ^a,b   Klein, John L ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; OPPORTUNISTIC INFECTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE;

ANIMALS; DRUG THERAPY; HUMANS; INFLAMMATION; NUCLEAR MEDICINE; OPPORTUNISTIC INFECTIONS; STEM CELL TRANSPLANTATION;

EID: 58849164973     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2008.10.003     Document Type: Review

References (63)

1. Lawn S.D., Bekker L.G., and Miller R.F. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5 (2005) 361-373
2. Appelbaum F.R. Haematopoietic cell transplantation as immunotherapy. Nature 411 (2001) 385-389
3. Stelljes M., Hermann S., Albring J., et al. Clinical molecular imaging in intestinal graft-versus-host disease: Mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood 111 (2008) 2909-2918
4. Goldenberg D.M., Sharkey R.M., Udem S., et al. Immumoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients. J Nucl Med 29 (1994) 1028-1034
5. Vinjamuri S., Hall A.V., Solanki K.K., et al. Comparison of 99mTc infection imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet 347 (1996) 233-235
6. Lupetti A., Welling M.M., Mazzi U., et al. Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. Eur J Nucl Med Mol Imaging 29 (2002) 674-679
7. Gamelli R.L., Liu H., He L.K., et al. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 59 (1996) 639-647
8. Gamelli R.L., Liu H., He L.K., et al. Alterations of glucose transporter mRNA and protein levels in brain following thermal injury and sepsis in mice. Shock 1 (1994) 395-400
9. Sugawara Y., Gutowski T.D., Fisher S.J., et al. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 26 (1999) 333-341
10. Ishimori T., Saga T., Mamede M., et al. Increased (18)F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation. J Nucl Med 43 (2002) 658-663
11. Hansson L., Ohlsson T., Valind S., et al. Glucose utilisation in the lungs of septic rats. Eur J Nucl Med 26 (1999) 1340-13414
12. Osman S., and Danpure H.J. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 19 (1992) 183-190
13. Forstrom L.A., Mullan B.P., Hung J.C., et al. 18F-FDG labelling of human leukocytes. Nucl Med Commun 21 (2000) 691-694
14. Dumarey N., Egrise D., Blocklet D., et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 47 (2006) 625-632
15. Bakheet S.M., and Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 28 (1998) 352-358
16. Gorospe L., Raman S., Echeveste J., et al. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 26 (2005) 671-687
17. Seshadri N., Kaur B., and Balan K. Disseminated cryptococcosis: Detection by F-18 FDG PET. Clin Nucl Med 32 (2007) 476-478
18. Castellucci P., Nanni C., Farsad M., et al. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: Prevalence and scan interpretation. Nucl Med Commun 26 (2005) 689-694
19. Mackie G.C. F-18 fluorodeoxyglucose positron emission tomographic imaging of cytomegalovirus pneumonia. Clin Nucl Med 29 (2004) 569-571
20. Nihashi T., Ito K., Kato T., et al. An abnormal accumulation of fluorine-18-FDG PET in cytomegalovirus enteritis-a case report. Ann Nucl Med 20 (2006) 75-78
21. Chamilos G., Macapinlac H.A., and Kontoyiannis D.P. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 46 (2008) 23-29
22. Nguyen B.D. F-18 FDG PET/CT imaging of disseminated coccidioidomycosis. Clin Nucl Med 31 (2006) 568-571
23. Vahid B., Wildemore B., Nguyen C., et al. Pulmonary blastomycosis masquerading as metastatic disease in the lung: A case report. Med Gen Med 8 (2006) 31
24. Azizirad O., Clifford D.B., Groger R.K., et al. Histoplasmoma: isolated central nervous system infection with Histoplasma capsulatum in a patient with AIDS. Case report and brief review of the literature. Clin Neurol Neurosurg 109 (2007) 176-181
25. Wilkinson M.D., Fulham M.J., McCaughan B.C., et al. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography. Clin Nucl Med 28 (2003) 234-235
26. Franzius C., Biermann M., Hülskamp G., et al. Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med 26 (2001) 232-233
27. Ho A.Y., Pagliuca A., Maisey M.N., et al. Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections. Br J Haematol 101 (1998) 392-393
28. Umeoka S., Koyama T., Saga T., et al. High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol 15 (2005) 2483-2486
29. Salhab K.F., Baram D., and Bilfinger T.V. Growing PET positive nodule in a patient with histoplasmosis: case report. J Cardiothorac Surg 1 (2006) 23
30. Sojan S.M., and Chew G. Pneumocystis carinii pneumonia on F-18 FDG PET. Clin Nucl Med 30 (2005) 763-764
31. Win Z., Todd J., and Al-Nahhas A. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin Nucl Med 30 (2005) 690-691
32. Hara T., Kosaka N., Suzuki T., et al. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: A positron emission tomography study. Chest 124 (2003) 893-901
33. Lin K.H., Wang J.H., and Peng N.J. Disseminated nontuberculous mycobacterial infection mimic metastases on PET/CT scan. Clin Nucl Med 33 (2008) 276-277
34. Zhuang H., Duarte P.S., Rebenstock A., et al. Pulmonary clostridium perfringens infection detected by FDG positron emission tomography. Clin Nucl Med 28 (2003) 517-518
35. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 42 (2001) 1412-1417
36. Ingui C.J., Shah N.P., and Oates M.E. Infection scintigraphy: Added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis. J Comput Assist Tomogr 31 (2007) 375-380
37. Bar-Shalom R., Yefremov N., Guralnik L., et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47 (2006) 587-594
38. O'Doherty M.J., Barrington S.F., Campbell M., et al. PET scanning and the human immunodeficiency virus positive patient. J Nucl Med 38 (1997) 1575-1583
39. Kang K., Lim I., and Roh J.K. Positron emission tomographic findings in a tuberculous brain abscess. Ann Nucl Med 21 (2007) 303-306
40. Mascarenhas N.B., Lam D., Lynch G.R., et al. PET imaging of cerebral and pulmonary Nocardia infection. Clin Nucl Med 31 (2006) 131-133
41. Rottenberg D.A., Sidtis J.J., Strother S.C., et al. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 37 (1996) 1133-1141
42. Hinkin C.H., van Gorp W.G., Mandelkern M.A., et al. Cerebral metabolic change in patients with AIDS: Report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci 7 (1995) 180-187
43. van Gorp W.G., Mandelkern M.A., Gee M., et al. Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. J Neuropsychiatry Clin Neurosci 4 (1992) 280-287
44. von Giesen H.J., Antke C., Hefter H., et al. Potential time course of human immunodeficiency virus type 1-associated minor motor deficits: Electrophysiologic and positron emission tomography findings. Arch Neurol 57 (2000) 1601-1607
45. Pohl P., Riccabona G., Hilty E., et al. Double-tracer SPECT in patients with AIDS encephalopathy: A comparison of 123I-IMP with 99Tcm-HMPAO. Nucl Med Commun 13 (1992) 586-592
46. Lee V.W., Antonacci V., Tilak S., et al. Intracranial mass lesions: sequential thallium and gallium scintigraphy in patients with AIDS. Radiology 211 (1999) 507-512
47. Antinori A., De Rossi G., Ammassari A., et al. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma. J Clin Oncol 17 (1999) 554-560
48. Lorberboym M., Wallach F., Estok L., et al. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients. J Nucl Med 39 (1998) 1366-1369
49. Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 50 (1998) 21-26
50. Palestro C.J., Love C., and Miller T.T. Diagnostic imaging tests and microbial infections. Cell Microbiol 9 (2007) 2323-2333
51. Gemmel F., Dumarey N., and Palestro C.J. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging 33 (2006) 1226-1237
52. Sharko A.M., Perlman S.B., Hinds P.W., et al. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Nat Acad Sci USA 93 (1996) 6425-6430
53. Wallace M., Pyzalski R., Horejsh D., et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute SHIV89,6PD infection in rhesus macaques. Virology 274 (2000) 255-261
54. Scharko A.M., Perlman S.B., Pyzalski R.W., et al. Whole body positron emission tomography in patients with HIV-1 infection. Lancet 362 (2003) 959-961
55. Brust D., Polis M., Davey R., et al. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: Impact of disease stage and therapy on pattern of nodal activation. Aids 20 (2006) 985-993
56. 99mTc DTPA aerosol transfer in the investigation of lung infections in HIV infection. Respir Med 83 (1989) 395-401
57. O'Doherty M.J., Page C.J., Bradbeer C.S., et al. Alveolar permeability in HIV patients with Pneumocystis carinii pneumonia. Genitourin Med 63 (1987) 268-270
58. 99mTc DTPA transfer/permeability in patients with HIV disease. Q J Nucl Med 39 (1995) 231-242
59. Rosso J., Guillon J.M., Parrot A., et al. Technetium-99m-DTPA aerosol and gallium-67 scanning in pulmonary complications of human immunodeficiency virus infection. J Nucl Med 33 (1992) 81-87
60. Kramer E.L., Sanger J.J., Garay S.M., et al. Gallium-67 scans of the chest in patients with acquired immunodeficiency syndrome. J Nucl Med 28 (1987) 1107-1114
61. Tuazon C.V., Delaney M.D., Simon G.L., et al. Utility of gallium-67 scintigraphy and bronchial washings in the diagnosis and treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 132 (1985) 1087-1092
62. Lee V.W., Fuller J.D., O'Brien M.J., et al. Pulmonary Kaposi sarcoma in patients with AIDS: Scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology 180 (1991) 409-412
63. Alavi A., Gupta N., Alberini J.L., et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 32 (2002) 293-321